{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:14Z","timestamp":1761870674282,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clml.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T11:06:53Z","timestamp":1415272013000},"page":"e135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Splenomegaly Secondary to Myeloproliferative Neoplasms and Portal Hypertension"],"prefix":"10.1016","volume":"15","author":[{"given":"Antonio","family":"Manenti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Forghieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Colasanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"MarioLuppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2014.10.005_bib1","doi-asserted-by":"crossref","unstructured":"Yan M, Geyer H, Mesa R, et\u00a0al. Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension. Clin Lymphoma Myeloma Leuk, Published online June 11, 2014; doi: 10.1016\/j.clml.2014.04.004.","DOI":"10.1016\/j.clml.2014.04.004"},{"key":"10.1016\/j.clml.2014.10.005_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.lpm.2014.02.024","article-title":"Splenomegaly in haematological malignancies and portal hypertension","volume":"43","author":"Manenti","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.clml.2014.10.005_bib3","first-page":"231","article-title":"Pathophysiology of portal hypertension","volume":"59","author":"Cichoz-Lach","year":"2008","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.clml.2014.10.005_bib4","series-title":"Sherlock's Diseases of the Liver and Biliary System","first-page":"57","article-title":"Hematological disorders of the liver","author":"Mistry","year":"2011"},{"key":"10.1016\/j.clml.2014.10.005_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.gassur.2005.06.022","article-title":"Arterioportal fistulas: introduction of\u00a0a\u00a0novel classification with therapeutic implications","volume":"10","author":"Guzman","year":"2006","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.clml.2014.10.005_bib6","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3748\/wjg.15.3128","article-title":"Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases","volume":"15","author":"Abu-Hilal","year":"2009","journal-title":"World J Gastroenterol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014004431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265014004431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:26:22Z","timestamp":1761870382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265014004431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2152265014004431"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2014.10.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenomegaly Secondary to Myeloproliferative Neoplasms and Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2014.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}